10q10k10q10k.net
ASCENTAGE PHARMA GROUP INTERNATIONAL

ASCENTAGE PHARMA GROUP INTERNATIONALAAPGEarnings & Financial Report

Nasdaq

AAPG Q4 2025 Key Financial Metrics

Revenue

$574.1K

Gross Profit

N/A

Operating Profit

N/A

Net Profit

N/A

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

YoY Growth

N/A

Financial Flow

ASCENTAGE PHARMA GROUP INTERNATIONAL Q4 2025 Financial Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL reported revenue of $574.1K for Q4 2025, with a net profit of N/A (N/A margin). Cost of goods sold was N/A.

Key Financial Metrics

Total Revenue$574.1K
Net ProfitN/A
Gross MarginN/A
Operating MarginN/A
Report PeriodQ4 2025

ASCENTAGE PHARMA GROUP INTERNATIONAL Quarterly Revenue & Net Profit History

ASCENTAGE PHARMA GROUP INTERNATIONAL quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 2025$574.1K—N/AN/A
Q2 2025$32.6M—N/AN/A

Income Statement

Q2 2025Q4 2025
Revenue$32.6M$574120
YoY GrowthN/AN/A

Balance Sheet

Q2 2025Q4 2025
AssetsN/AN/A
LiabilitiesN/AN/A
EquityN/AN/A

Cash Flow

No data available for this period